Myasthenia gravis (MG), the most common autoimmune disease of neuromuscular junction (NMJ), is heterogeneous in terms of pathophysiology, which is determined by the pathogenic antigen of autoantibodies targeting to synaptic proteins at the NMJs. Currently, patients suspected with MG are routinely screened for the presence of autoantibodies against acetylcholine receptor (AChR) or musclespecific kinase (MuSK) using a cell-based assay (CBA) that involves the expression of target synaptic membrane protein in heterologous cell lines. However, some autoantibodies may only show reactivity for binding to densely clustered AChR in the physiological conformation, while AChR clustering is known to involve signaling events orchestrated by over a dozen of postsynaptic proteins. To improve the existing serological diagnosis of MG, this study explored the possibility of using the well-established Xenopus primary culture system as a novel CBA for MG. Here, by examining the pathogenic effects of four MG human plasma samples, we found that the samples from both seropositive and seronegative MG patients effectively induced the disassembly of aneural AChR clusters in cultured Xenopus muscle cells, as well as the nerve-induced AChR clusters in the nerve-muscle co-cultures. Importantly, the disassembly of AChR clusters was spatio-temporally correlated to the disappearance of actin depolymerizing factor (ADF)/cofilin, an actin regulator involved in AChR trafficking and clustering. Taken together, this study develops a reliable CBA using Xenopus primary cultures for screening the pathogenicity of human MG plasma samples, and providing a platform for investigating the pathogenic mechanisms underlying the endocytic trafficking and degradation of AChRs at NMJs in MG patients.
Introduction
At the neuromuscular junction (NMJ), the postsynaptic membrane in skeletal muscles contains a very high density of acetylcholine receptor (AChR) molecules to make the neurotransmission between motor neurons and muscle fibers more efficient. Myasthenia gravis (MG) is a prototypical antibody-mediated autoimmune disease that is characterized by the weakness of the skeletal muscle contraction, ranging from minor eyelid movement problems to serious breathing defects. About 85% of MG patients have anti-AChR antibodies in their serum (seropositive MG, SPMG), which recognize a complex array of epitopes that varies between each individual patient (Lindstrom, 2000) . Therefore, the epitope recognized by the antiAChR antibody determines its pathogenic potential. The pathogenic antibody binds to the extracellular domains of AChR on the postsynaptic membrane that are accessible for the crosslinking of nearby AChR molecules (Beroukhim and Unwin, 1995) . However, recent studies showed that the remaining 15% of MG patients that are negative to the presence of anti-AChR antibodies (identified initially as seronegative MG, SNMG) may also contain pathogenic antibodies against other postsynaptic proteins, namely musclespecific receptor tyrosine kinase (MuSK), low-density lipoprotein receptor-related protein 4 (Lrp4), or agrin (Higuchi et al., 2011; Hoch et al., 2001; Zhang et al., 2014) . Currently, a tremendous amount of research has been devoted to identifying the novel targets for autoantibodies in patients initially classified as SNMG.
The antibody-mediated crosslinking of AChR molecules, or possibly other postsynaptic membrane proteins, increases their internalization and degradation rates (termed antigenic modulation), thus contributing to the reduced density of AChR clusters at the NMJs in MG patients. In addition, the effects of autoantibodies binding to a small fraction of AChRs are greatly amplified by the assembly of membrane attack complex, which attracts phagocytes in mediating a complement-dependent cytotoxic response at the endplates (termed complement-mediated cell lysis). This causes the destructive changes in the junctional folds of postsynaptic Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/developmentalbiology membrane resulting in the shedding of AChR-enriched membrane fragments into the synaptic space (Mendell et al., 1996) . Although both antigenic modulation and complement-mediated cell lysis are involved in MG pathogenesis, the stabilization of AChR by rapsyn over-expression is able to prevent AChR loss in the experimental animal MG rats, even in the presence of the activated complement (Losen et al., 2005; Mendell et al., 1996) . Hence, this suggested that the prevention of antigenic modulation may represent a possible therapy for MG.
At present, the most common CBA for MG requires the transfection of the target auto-antigens in the heterologous cell lines (Zisimopoulou et al., 2013 ). The transfected cells are then incubated with diluted MG patient serum, and the presence of bound patient autoantibodies on the cells is detected by immunocytochemical analysis. However, this assay can only demonstrate the binding of autoantibodies to the exogenously expressed postsynaptic proteins in heterologous cells, but not the endocytosis of clustered AChR molecules that are endogenously expressed in skeletal muscle fibers. Moreover, recent studies showed that some autoantibodies in MG patients can only bind to and react with the densely clustered AChRs in the physiological conformation (Devic et al., 2014; Jacob et al., 2012) , which could not be reproduced in heterologous cell lines with the expression of one or a few postsynaptic proteins. With these limitations, this study therefore aims to develop a novel CBA using Xenopus tissue cultures to validate the pathogenicity of autoantibodies in MG patient plasma on the disassembly of AChR clusters.
Xenopus tissue cultures have long been used as the model system for studying the NMJ development in vitro (Anderson and Cohen, 1977; Kuromi and Kidokoro, 1984; Peng et al., 1991) . In the absence of nerve innervation, AChRs are expressed in cultured Xenopus muscle cells, and are spontaneously aggregated to form the pre-existing clusters, also known as hotspots or aneural clusters (Lee et al., 2009; Rochlin and Peng, 1990) . Intriguingly, these morphologically complex aneural AChR clusters can also be found in a mouse muscle cell line, in which they undergo a similar topological transformation mirroring the observations during synaptic maturation of NMJs in vivo (Kummer et al., 2004) . In Xenopus nerve-muscle co-cultures, the formation of NMJs can easily be followed upon the physical contact between the spinal neurons and muscle cells by visualizing the dynamic redistribution of AChR molecules from the aneural clusters to the nascent synaptic sites (Anderson and Cohen, 1977; Lee et al., 2009 ). Importantly, cDNAs encoding α, γ, and δ subunits of the Xenopus AChR have been shown to share a high amino acid sequence homology to their Torpedo homologs (Baldwin et al., 1988) . The expression of ε subunit is delayed with respect to that of γ subunit during development in Xenopus embryos, consistent with the transition in the subunit composition of the AChR from embryonic to adult properties in the mammalian NMJs (Missias et al., 1996; Reuer et al., 1994) . Taken together, the use of aneural and synaptic AChR clusters that are endogenously expressed and assembled in the physiological conformation in Xenopus tissue cultures serves as a reliable assay for screening the pathogenicity of MG human patient plasma samples. Since the endocytosis of cross-linked AChRs is likely the rate-limiting step to the antigenic modulation in vitro and in vivo (Lindstrom and Einarson, 1979) , this CBA can also be employed to elucidate the pathogenic mechanisms underlying the internalization and degradation of AChRs and other postsynaptic proteins during the pathogenesis of MG.
Materials and methods

Xenopus embryo microinjection and primary cell culture preparation
A DNA construct encoding the green fluorescent protein (GFP)-tagged Xenopus ADF/cofilin (XAC) was micro-injected into one blastomere of 2-cell stage Xenopus embryos using an oocyte injector, Nanoject (Drummond Scientific) as described previously (Lee et al., 2009; Lee et al., 2014) . Typically, each embryo was injected with 20-100 pg of DNA. GFP-expressing embryos were screened for primary cell culture preparation. For both GFPexpressing and wild-type non-injected embryos, muscle cells were dissociated from the myotomal tissues of the 1-d-old embryos at Nieuwkoop and Faber stage 19-22 (Nieuwkoop and Faber, 1994) after collagenase treatment, and were plated on glass coverslips coated with a mixture of cell attachment substrates, entactincollagen IV-laminin (Millipore). The muscle cell cultures were grown in culture medium containing 10% Leibovitz's L-15 medium (vol/vol; Sigma), 87% Steinberg's solution (vol/vol; 60 mM NaCl, 0.67 mM KCl, 0.35 mM Ca(NO 3 ) 2 , 0.83 mM MgSO 4 , 10 mM HEPES, pH 7.4), 1% fetal bovine serum (vol/vol), 1% penicillin/ streptomycin (vol/vol) and 1% gentamicin sulfate (vol/vol), and were kept in room temperature at $ 23 1C for at least 1 d before experiments begin to enhance cell attachment and to develop aneural AChR clusters. To make nerve-muscle co-cultures, we plated dissociated spinal neurons on 1-d-old muscle cultures to induce neuromuscular synaptogenesis, and then observed the nerve-induced AChR clusters after 2 d in co-culture. All of the experiments involving Xenopus frogs and embryos were carried out in accordance with the approved protocol by the Institutional Animal Care and Use Committee (IACUC) of the National University of Singapore.
Live labeling of acetylcholine receptors and cell fixation
The localization of AChR clusters was labeled with 1 mg/ml rhodamine-conjugated α-bungarotoxin (Rh-BTX, Life Technologies) for 45 min in live muscle cells or nerve-muscle co-cultures, then the cultures were washed extensively with culture medium for at least 3 times. To observe live cells at high magnification with oil immersion objectives, glass coverslips with cultured cells were mounted on custom-made sealed chambers containing culture medium with or without MG patient plasma. In some experiments, Xenopus muscle cells were fixed at specific time-points with À20 1C cold ethanol for 3 min or 4% paraformaldehyde for 15 min, then the cultures were washed extensively with phosphate buffered saline (PBS) for at least 3 times. The coverslips were then mounted on glass slides with an anti-bleaching agent Fluoromount-G (Southern Biotech) for later examination.
Microscopy and data analysis
All wide-field fluorescence imaging on live and fixed cell cultures was performed on inverted fluorescence microscopes, IX83 (Olympus) or TE2000U (Nikon). Digital images were acquired by an ORCA D2 CCD camera (Hamamatsu) through the use of an open source microscopy software Micro-Manager (Edelstein et al., 2010) or by a CoolSNAP ES CCD camera (Photometrics) through the use of MetaMorph imaging software (Molecular Devices). All images were taken with identical settings between the control and experimental groups. The aneural and nerve-induced AChR clusters were quantified by scoring the presence or absence of AChR clusters in cultured muscle cells. The presence of nerveinduced AChR clusters was quantified by first identifying nervemuscle contacts in phase-contrast and then calculating the percentages of nerve-muscle contact sites with AChR aggregates. Data were shown as mean 7SEM and the statistical significance of differences between the control and experimental groups was assessed by Student's t-test.
Results and discussion
MG patient plasma induces the disassembly of spontaneously formed aneural AChR clusters
The current CBA for MG involves the use of heterologous cell lines exogenously expressed with target synaptic membrane proteins that may not react with the presence of possible autoantibodies against densely clustered AChRs in the physiological condition (Devic et al., 2014; Jacob et al., 2012) . To improve the CBA for screening the pathogenicity of autoantibodies in MG patient plasma samples, we employed the well-established Xenopus primary culture system that allows the multifaceted investigation of NMJ formation and maintenance in vitro (Peng et al., 1991) . In this study, we have systematically evaluated the pathogenicity of four MG patient plasma samples, which were obtained from two SPMG patients (anti-AChR-positive) and two SNMG patients (anti-AChR-negative) by plasma exchange, on the disassembly of aneural and synaptic AChR clusters in cultured Xenopus muscle or nerve-muscle co-cultures, respectively. The detailed clinical characteristics of the MG patients were shown in Table 1 .
We first examined the effects of MG patient plasma samples on the aneural AChR clusters in 3-d-old cultured Xenopus muscle cells. AChR molecules were labeled with a low concentration of Rh-BTX, which binds to the α1 subunit of AChR molecules (Gershoni et al., 1983) . Consistent with our previous study (Lee et al., 2009 ), we observed one complex structure of aneural AChR clusters in the whole muscle cell that was spontaneously formed in the surface membrane when the muscle cells were cultured on the laminin-containing substrate (Fig. 1A, inset in control) . These aneural AChR clusters share several characteristics with the mature postsynaptic apparatus in vivo, including the presence of multiple postsynaptic markers, and the transformation of cluster morphology during development (Kummer et al., 2004) . Here, we treated the cultured Xenopus muscle cells with either SPMG or SNMG plasma samples for 4 h, followed by cell fixation for imaging and quantitative analysis. We found that all 4 MG plasma samples, regardless of SPMG or SNMG, effectively induced the disassembly of aneural AChR clusters in cultured muscle cells, while we did not observe any noticeable change in the clusters upon the treatment of cultured muscle cells with normal human serum (NHS) (Fig. 1A ). Quantitative analysis on over 250 muscle cells from 5 independent experiments further supported that both SPMG and SNMG patient plasma samples were equally pathogenic in inducing the disassembly of aneural AChR clusters in cultured Xenopus muscle cells (Fig. 1B) . For the two SPMG patient plasma, the percentages of muscle cells with AChR clusters were significantly reduced to $ 38% (patient 1) or $ 36% (patient 2), compared to the untreated control. Likewise, the two SNMG patient plasma samples also showed a significant reduction in the percentage of muscle cells with AChR clusters to $ 39% (patient 3) or $ 19% (patient 4). In contrast, NHS only slightly, and not significantly, affected AChR clustering (Fig. 1B) . Since AChR molecules were labeled with Rh-BTX that binds to their α1 subunit (Gershoni et al., 1983) , this may potentially interfere with the binding of autoantibodies to the Rh-BTXlabeled AChRs leading to a false negative result. However, all MG plasma samples tested in this study effectively induced the disassembly of Rh-BTX-labeled AChR clusters, suggesting that the Rh-BTX-binding site of AChR molecules was not at the antigen of autoantibodies in these samples. To avoid the potential false negative results, AChR labeling with Rh-BTX in cultured muscle cells could be performed after the treatment with patient plasma samples. If the pathogenic autoantibodies and Rh-BTX bind to the same site of AChR molecules, the plasma treatment would block the subsequent Rh-BTX labeling and result in a large reduction of AChR signals in cultured muscle cells. Next, we performed time-lapse imaging to investigate the dynamic changes in the morphology and density of aneural AChR clusters in cultured Xenopus muscles upon MG plasma treatment. Specifically, we first labeled all surface AChRs in cultured muscle cells with Rh-BTX at 0 h, then the same AChR clusters were followed up to 40 h in the presence or absence of the SPMG plasma. In the control muscle cells, AChR clusters appeared to be relatively stable as we did not detect a drastic change in terms of the size and intensity of the fluorescence signals from Rh-BTXlabeled AChRs ( Fig. 2A) , suggesting the slow turnover rate of surface AChRs and the minimal photo-bleaching effects during the entire imaging period. In contrast, the size and intensity of AChR clusters were gradually reduced in cultured muscle cells treated with the SPMG plasma (Fig. 2B) . In this example, the aneural AChR cluster had largely disappeared at 40-h time point after the plasma treatment. Similar results were obtained when cultured Xenopus muscle cells were treated with the SNMG patient plasma samples (data not shown). These data suggested that cultured Xenopus muscle cells endogenously express all the postsynaptic proteins required for the formation of the stable aneural AChR clusters in the muscle membrane; and both SPMG and SNMG patient plasma may contain autoantibodies against AChR molecules or other postsynaptic membrane proteins that destabilize the aneural AChR clusters leading to their disassembly.
MG patient plasma induces the disassembly of nerve-induced synaptic AChR clusters
Regardless of the striking similarity between aneural and synaptic AChR clusters, the differences in their associated cytoskeletal scaffolds may result in the differential turnover rate and stability of these two pools of surface AChRs (Gervasio et al., 2007; Sadasivam et al., 2005) . In addition, a previous study suggested that autoantibodies from MG patient plasma show a higher immunochemical properties against extra-synaptic than synaptic AChR clusters (Dwyer et al., 1981) . Therefore, an experimental setup involving co-cultures of Xenopus spinal neurons and muscle cells was also used to investigate the pathogenic effects of SPMG and SNMG patient plasma on the synaptic AChR clusters induced by spinal motor neurons. In this experiment, we prepared the Xenopus nerve-muscle co-cultures by plating the dissociated neural tube tissues in 1-d-old cultured Xenopus muscle cells. When the spinal neuron comes into contact with the muscle cell, synaptogenesis follows (Dai and Peng, 1996) , as evidenced by the clustering of AChR at the nerve-muscle contact sites (Fig. 3A , arrows in control). However, we detected a large reduction in the numbers of nerve-induced AChR clusters in the 2-d-old Xenopus nerve-muscle co-cultures treated with either SPMG or SNMG plasma for 4 h (Fig. 3A, arrowheads) . Quantification from a pool of muscle cells with spinal neuron contacts showed that both SPMG and SNMG plasma samples effectively induced the disassembly of nerve-induced synaptic AChR clusters in cultured Xenopus nerve-muscle co-cultures, while NHS treatment did not significantly affect the nerve-induced AChR clustering (Fig. 3B) . Specifically, the numbers of nerve-muscle contacts with AChR clusters were reduced to $ 66% (patient 1) or $ 52% (patient 2), compared to the untreated control nerve-muscle co-cultures. Likewise, two SNMG patient plasma also showed a large reduction in the numbers of nerve-induced AChR clusters at the contact sites to $ 52% (patient 3) or $ 44% (patient 4). It is of interest to note that the synaptic AChR clusters were less susceptible to their disassembly than the aneural AChR clusters in response to the treatment with the same patient plasma sample (Figs. 1B and 3B ). This could be contributed by the differences in the cytoskeletal scaffolds associated to the synaptic versus aneural AChR clusters (Bloch et al., 1989; Campanelli et al., 1994) . In addition, nervesecreted agrin and growth factors may also increase the metabolic stability of synaptic AChR clusters (Dai and Peng, 1992; Phillips et al., 1997) , thus dampening the pathogenic effects of the patient plasma on synaptic AChR clusters. Our future study will examine the nerve-secreted factors and the differences in cytoskeletal scaffolding proteins underneath those nerve-induced AChR clusters that are more resistant towards the MG plasma treatment.
Among all the SPMG and SNMG patient plasma samples tested in this study, the plasma sample from patient 4 was identified to be the most pathogenic in inducing the disassembly of aneural and synaptic AChR clusters in Xenopus muscle and nerve-muscle co-cultures, respectively (Figs. 1B and 3B) . Since anti-AChR autoantibodies were not present in this SNMG patient plasma, the identification of any possible novel antigen(s), which showed a higher pathogenicity than anti-AChR autoantibodies, remains to be investigated. A recent study showed that autoantibodies against MuSK can cause tyrosine phosphorylation of MuSK and AChR β-subunit, thus accelerating MuSK internalization from the plasma membrane (Cole et al., 2010) . This suggested that some autoantibodies in MG patients may impair NMJs by influencing the posttranslational modification and stability of postsynaptic proteins. Therefore, in addition to the antigenic modulation pathway of the crosslinking-induced endocytosis and degradation of postsynaptic proteins, some SNMG patient plasma samples may cause a more severe disruption of AChR clusters than the SPMG samples.
Similar to the aneural AChR clusters, we also performed timelapse imaging to investigate the dynamic changes in the nerveinduced AChR clusters upon the treatment of MG plasma samples (Fig. 4) . In the control nerve-muscle co-culture, the nerve-induced AChR clusters were quite stable throughout the entire imaging period of 48 h (Fig. 4A, arrows) . However, in the co-culture treated with the SPMG plasma sample, we observed a gradual disassembly of AChR clusters at the nerve-muscle contacts (Fig. 4B) . In this example, we identified 3 nerve-induced AChR clusters at the nerve-muscle contact sites before the plasma treatment (Fig. 4B , arrows at 0 h). At 20 h after the treatment, 2 nerve-induced AChR clusters completely disappeared (Fig. 4B , arrowheads at 20 h), while the size and intensity of the remaining nerve-induced AChR clusters also drastically reduced over the next 28 h (Fig. 4B , arrows in 48 h). Likewise, treatment of Xenopus nerve-muscle co-cultures with the SNMG plasma sample also resulted in a gradual disassembly of the nerve-induced AChR clusters (data not shown). These data suggested that the MG patient plasma contains autoantibodies against AChR or other postsynaptic proteins that cause a gradual disassembly of synaptic AChR clusters at the NMJs.
Correlation between ADF/cofilin localization and AChR cluster disassembly
Our recent study showed that a family of an actin-binding protein, ADF/cofilin, regulates the dynamic actin turnover for the surface targeting of AChRs via vesicular trafficking at developing NMJs (Lee et al., 2009) . We hypothesized that a similar cytoskeletal regulation mediated by ADF/cofilin is involved in the induction of AChR endocytosis leading to the disassembly of AChR clusters during MG pathogenesis. To test this hypothesis, we further examined the dynamic localization of ADF/cofilin in live muscle cells and its correlation to the disassembly of AChR clusters induced by the SPMG patient plasma. To examine the spatial and temporal correlation between ADF/cofilin localization and AChR cluster disassembly upon the SPMG patient plasma treatment, we performed dual-channel live-cell imaging on muscle cultures expressing fusion proteins of XAC and GFP in conjunction with Rh-BTX labeling (Fig. 5) . We found that GFP-XAC was highly enriched at the aneural AChR clusters in cultured muscle cells at the beginning of this time-lapse series (Fig. 5A, 0 h ). Consistent with our data in Figs. 1 and 2 , treatment of cultured Xenopus muscle cells with the SPMG patient plasma sample effectively induced the disassembly of the aneural AChR clusters (Fig. 5A, top  row) . Intriguingly, we also observed the progressive reduction of GFP-XAC puncta within the aneural clusters (Fig. 5A, middle row) , that was spatially correlated to the disassembly of AChR clusters. Quantification showed that the disappearance of GFP-XAC was tightly coupled temporally to the AChR cluster disassembly induced by the SPMG plasma sample treatment (Fig. 5B) . These data implicated the requirement of ADF/cofilin for the maintenance of AChR clusters, and the pathogenic plasma from the MG patient may actively or passively disrupt the localization of ADF/ cofilin for the maintenance of aneural or synaptic AChR clusters. Furthermore, our previous study showed that overexpression of GFP-XAC phosphorylation mutants in Xenopus muscle cultures reduces the number and size of synaptic AChR clusters induced by nerve innervation (Lee et al., 2009) , suggesting that the activity of ADF/cofilin is required for the maintenance of synaptic AChR clusters. However, the exact function of ADF/cofilin in the regulation of AChR cluster disassembly warrants further investigation in the future.
Previous studies have indicated the essential role of the dynamic remodeling of actin cytoskeleton during both endocytosis and exocytosis (Engqvist-Goldstein and Drubin, 2003; Lanzetti, 2007; Schafer, 2002) . Based on our recent studies showing the requirement of ADF/cofilin for surface delivery of AChR to the postsynaptic membrane by exocytosis (Lee et al., 2009 ), the present study showed that ADF/cofilin may also be involved in the autoantibody-mediated endocytosis leading to the disassembly of AChR clusters during the pathogenesis of MG. ADF/cofilin, through its severing activity, could generate new actin barbed ends and monomeric G-actin, which in turn could enhance the turnover rate of actin filaments to facilitate endocytosis (Bamburg, 1999; Sarmiere and Bamburg, 2004) . Further studies on the regulation of ADF/cofilin activity by its upstream regulators will provide additional evidences showing the spatiotemporal regulation of actin dynamics by localized ADF/cofilin at sites of the autoantibody-mediated AChR endocytosis in MG pathogenesis.
In summary, considering the potential pitfalls of the current cell-based diagnostic assays as described above, it is essential to develop reliable, sensitive and specific tools that help to diagnose MG, even at the early stage of pathogenesis. Despite the fact that most CBAs are relatively labor intensive, the use of cultured Xenopus tissue cultures would still serve as a reliable, alternative CBA to screen the pathogenicity of MG human patient samples for the disassembly of AChR clusters in vitro. The assay described in this study may be employed to distinguish the disease severity among different patients, to monitor the course of the disease and the efficacy of treatment received for a particular MG patient, and to study the pathogenic mechanisms underlying the autoantibody-induced AChR endocytosis and degradation during MG pathogenesis.
